Pages that link to "Q54560810"
Jump to navigation
Jump to search
The following pages link to Clinical pharmacology and efficacy of vancomycin in pediatric patients. (Q54560810):
Displaying 50 items.
- Lack of effect of vancomycin and gentamicin on auditory function in guinea pigs (Q30532055) (← links)
- Pharmacokinetics of vancomycin in oncology egyptian paediatrics: a dosage adjustment trial (Q33555334) (← links)
- Rational prescribing of antibacterials in hospitalised children (Q33573965) (← links)
- Antibacterial-induced nephrotoxicity in the newborn (Q33604536) (← links)
- Intraventricular vancomycin in the treatment of ventriculitis associated with cerebrospinal fluid shunting and drainage (Q33629799) (← links)
- Antibiotics in neonatal infections: a review. (Q33736248) (← links)
- Accuracy of measured vancomycin serum concentrations in patients with end-stage renal disease (Q33814560) (← links)
- Outcome assessment of minimizing vancomycin monitoring and dosing adjustments (Q33860155) (← links)
- Pharmacodynamics of vancomycin for the treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis (Q33976683) (← links)
- A population pharmacokinetic model for vancomycin in pediatric patients and its predictive value in a naive population (Q33978650) (← links)
- Cerebrospinal fluid penetration and pharmacokinetics of vancomycin administered by continuous infusion to mechanically ventilated patients in an intensive care unit (Q33979524) (← links)
- Therapeutic monitoring of vancomycin according to initial dosing regimen in pediatric patients (Q34494676) (← links)
- Prediction of vancomycin pharmacodynamics in children with invasive methicillin-resistant Staphylococcus aureus infections: a Monte Carlo simulation (Q34989352) (← links)
- Current recommended dosing of vancomycin for children with invasive methicillin-resistant Staphylococcus aureus infections is inadequate (Q35004264) (← links)
- Comparison of conventional dosing versus continuous-infusion vancomycin therapy for patients with suspected or documented gram-positive infections (Q35123139) (← links)
- Pharmacokinetics of vancomycin in critically ill infants undergoing extracorporeal membrane oxygenation. (Q35124226) (← links)
- Selecting antibacterials for outpatient parenteral antimicrobial therapy : pharmacokinetic-pharmacodynamic considerations (Q35185724) (← links)
- Dose regimen for vancomycin not needing serum peak levels? (Q35292492) (← links)
- Effects of hepatic function on vancomycin clinical pharmacology (Q35740505) (← links)
- Vancomycin: pharmacokinetics and administration regimens in neonates (Q35771508) (← links)
- Effect of obesity on vancomycin pharmacokinetic parameters as determined by using a Bayesian forecasting technique (Q35809992) (← links)
- Population pharmacokinetics of vancomycin in patients receiving extracorporeal membrane oxygenation (Q35826801) (← links)
- Defining risk factors for red man syndrome in children and adults (Q35906008) (← links)
- Clinical pharmacokinetics of vancomycin in the neonate: a review (Q36104107) (← links)
- Clinical Pharmacology Studies in Critically Ill Children. (Q36120465) (← links)
- Correlation of vancomycin dosing to serum concentrations in pediatric patients: a retrospective database review (Q36290499) (← links)
- Predictive Performance of Physiologically Based Pharmacokinetic and Population Pharmacokinetic Modeling of Renally Cleared Drugs in Children (Q37283027) (← links)
- An updated comparison of drug dosing methods. Part IV: Vancomycin (Q37742573) (← links)
- Assessment of Vancomycin Dosing and Subsequent Serum Concentrations in Pediatric Patients (Q37869274) (← links)
- Clinical pharmacokinetics of antibacterial drugs in neonates (Q37956835) (← links)
- Vancomycin Serum Concentration Monitoring : The Middle Ground is Best (Q38194525) (← links)
- Vancomycin therapeutic drug monitoring: is it necessary? (Q38566835) (← links)
- Determining the optimal vancomycin daily dose for pediatrics: a meta-analysis. (Q38641774) (← links)
- Methicillin-resistant Staphylococcus aureus: pediatric perspective (Q39643337) (← links)
- Use of serum drug concentrations in surgical patients (Q39653352) (← links)
- Clinical pharmacokinetics of vancomycin (Q39743278) (← links)
- Vancomycin: an update (Q39746652) (← links)
- Vancomycin pharmacokinetics and dose recommendations for preterm infants (Q39827450) (← links)
- Current therapy of acute bacterial meningitis in children: Part II. (Q39845217) (← links)
- The Immune Compromised Host (Q40145531) (← links)
- Pharmacokinetic Optimisation of Vancomycin Therapy (Q40467559) (← links)
- The importance of pharmacokinetic/pharmacodynamic surrogate markers to outcome. Focus on antibacterial agents (Q40517235) (← links)
- Pharmacokinetics of anti-infective agents in paediatric patients (Q40686147) (← links)
- Vancomycin administration into the cerebrospinal fluid: a review (Q40842373) (← links)
- Pharmacokinetics and Administration Regimens of Vancomycin in Neonates, Infants and Children (Q40888996) (← links)
- Pharmacodynamics of antimicrobial therapy in surgery. (Q41014098) (← links)
- A critical evaluation of vancomycin for treatment of bacterial meningitis (Q41599308) (← links)
- Adverse effects of vancomycin in children: a review of 22 cases (Q41734564) (← links)
- Constant rate infusion of vancomycin in premature neonates: a new dosage schedule (Q41883396) (← links)
- Vancomycin kinetics in plasma and synovial fluid following intravenous administration in horses (Q42607001) (← links)